PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial - Dormandy, JA; Charbonnel, B; Eckland, DJ (Lancet, 2005)
et al.